glp 1 hepatic steatosis Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive Efficacy and safety of anti-obesity

Though these drugs have been deemed effective in treating T2DM, the Food and Drug Administration (FDA) and some members of the scientific community have questioned the safety of these therapeutics relative to important cardiovascular endpoints

Yale researchers have discovered that GLP-1 receptor agonist drugs, like Ozempic and Wegovy, may offer promising new ways of treating alcohol use disorder.

Do not use if outer seal is broken or missing

The first GLP-1 receptor agonist entered clinical use in 2005, marking a paradigm shift in metabolic disease treatment

Eligibility for a GLP-1 medication depends on a Service Members diagnosis, prior authorization, and/or medical necessity.Service Members who are overweight with other risk factors or obese should work with their Department of War (DoW) medical officer or Primary Care Manager/Provider to determine if a GLP-1 medication is appropriate before starting these medications.The use of GLP-1 medications during training, deployments, or operational platforms might not be authorized

Learn how to get a GLP-1 prescription from your doctor, including what to expect during your consultation and tips to navigate the process effectively.